The expanding role of GLP-1 medications beyond weight loss, such as their potential to treat conditions like sleep apnea or chronic heart failure, represents an exciting shift in healthcare
As with other drugs in the incretin-based therapy class, the most commonly reported side effects of retatrutide in clinical trials have been gastrointestinal in nature
One difference between their model and the one reported here is that deletion of Gclc is induced in hepatocytes of adult mice (which are slowly proliferating), compared to theirs, where deletion of Gclc occurred in hepatocytes of growing animals (which are rapidly proliferating)
This study was supported by grants from National Natural Science Foundation of China [Grant Nos
With just a smartphone, tablet, or computer, you can converse with our proficient semaglutide providers
Retatrutide is still in Phase 3 clinical trials as of early 2026, so its price and availability are not set yet